Nitric oxide gas
Active Purchase Order Awarded Last action
- Contract number
- HT001426PE040
- Awardee
-
INO Therapeutics LLC UEI XXQHL619FUN6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $40,200
Award facts
- Contract value 100% obligated
- $40,200.00 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $40.2K firm fixed-price purchase order to INO Therapeutics LLC for nitric oxide gas, with a performance location in Bethesda, Maryland and an ultimate completion date of January 31, 2027. This contract represents a child order under INO Therapeutics' larger Blanket Purchase Agreement with the Defense Health Agency, which was established on March 20, 2025, with a $404.2K ceiling value through March 19, 2030. No small business set-aside was applied to this award. The contract procures inhaled nitric oxide therapeutic gas supplies essential for critical care respiratory treatments, including INOMAX cylinders and related delivery systems that support patient care across federal military medical facilities.
INO Therapeutics LLC, a foreign-owned, for-profit organization headquartered in Hazelwood, Missouri, brings extensive federal contracting experience as a specialized supplier of therapeutic medical gases and inhalation therapy services to the Department of Veterans Affairs and Defense Health Agency. The company maintains three active blanket purchase agreements across multiple Veterans Integrated Service Networks and federal agencies, having successfully delivered nitric oxide gas supplies and respiratory therapy services to prominent military medical centers including Walter Reed National Military Medical Center, Tripler Army Medical Center, and Naval Medical Center San Diego. This purchase order reflects the company's established role as a critical supplier of advanced respiratory treatments for neonatal, pediatric, and adult patient populations throughout the federal healthcare system.
Quick answers
Who was awarded contract HT001426PE040?
HT001426PE040 was awarded to INO Therapeutics LLC by Defense Health Agency (Department of Defense) on February 1, 2026.
How much is contract HT001426PE040 worth?
The government has obligated $40,200 on HT001426PE040.
Was contract HT001426PE040 competed?
The extent of competition for HT001426PE040 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award